Non-Myeloablative (NMA) Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine and Total Body Irradiation (Bu/Flu/TBI) Conditioining: Results of a Phase II Trial

Saved in:
Bibliographic Details
Published inBiology of blood and marrow transplantation Vol. 20; no. 2; p. S215
Main Authors Brammer, Jonathan E., MD, Stentz, Alex, MPH, Dibb, James, Frires, Rachel, BA, Meyers, Gabrielle, MD, Curtin, Peter, MD, Kovacsovics, Tibor, MD, Leis, Jose, MD, PhD, Gajewski, James, MD, FACP, Maziarz, Richard T., MD
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2014
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2013.12.362